Summit Therapeutics stock shot higher this September in response to outstanding clinical-trial results. The company's lead candidate is a cancer therapy that's already approved in China. Summit's ...
AUSTIN, Texas, June 22, 2023 /PRNewswire/ -- Summit Hotel Properties, Inc. (NYSE: INN) (the "Company") today announced that it has successfully completed the refinancing of its $600 million senior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results